Income Statement Burning Rock Biotech Limited

Stocks

BNR

US12233L2060

Healthcare Facilities & Services

Market Closed - Nasdaq 16:30:00 2026-08-28 EDT			5-day change	1st Jan Change
10.19 ^USD	+1.90%		+4.19%	-49.43%

07-20	Burning Rock Biotech Limited and Myriad Genetics Announce Global Strategic Technology Licensing Partnership to Expand Hrd Testing Worldwide	CI
07-02	Burning Rock Biotech Insider Bought Shares Worth $6,182,172, According to a Recent SEC Filing	MT

50ed6d20e.yMgOyezQTg5Ugei0YEpgn2XoMrGlab4f72vODGoDOAw._vlK-qiyHUEgsJ71AXwC8hSiWYP0X8dHvgGHTw5tf2CXumGC27IeZAD5iw

Published financial data: BURNING ROCK BIOTECH LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Revenues	508M	563M	537M	516M	540M
Total Revenues	508M	563M	537M	516M	540M
Cost of Goods Sold, Total	144M	183M	174M	153M	137M
Gross Profit	364M	380M	363M	362M	403M
Selling General & Admin Expenses, Total	796M	942M	686M	453M	291M
R&D Expenses	365M	419M	347M	232M	166M
Other Operating Expenses, Total	1.16B	1.36B	1.03B	685M	458M
Operating Income	-797M	-980M	-669M	-322M	-54.84M
Interest Expense, Total	-1.54M	-	-	-	-30K
Interest And Investment Income	3.46M	9.36M	17.96M	12.21M	8.05M
Net Interest Expenses	1.92M	9.36M	17.96M	12.21M	8.02M
Currency Exchange Gains (Loss)	-854K	1.55M	-420K	-100K	-6.71M
Other Non Operating Income (Expenses)	199K	254K	484K	4.71M	-257K
EBT, Excl. Unusual Items	-796M	-969M	-651M	-306M	-53.79M
Asset Writedown	-	-	-	-35.13M	-
EBT, Incl. Unusual Items	-796M	-969M	-651M	-341M	-53.79M
Income Tax Expense	899K	1.98M	2.39M	5.88M	1.56M
Earnings From Continuing Operations	-797M	-971M	-654M	-347M	-55.35M
Net Income to Company	-797M	-971M	-654M	-347M	-55.35M
Net Income - (IS)	-797M	-971M	-654M	-347M	-55.35M
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-797M	-971M	-654M	-347M	-55.35M
Net Income to Common Excl. Extra Items	-797M	-971M	-654M	-347M	-55.35M
Per Share Items
Net EPS - Basic	-76.45	-93.47	-63.84	-33.67	-5.21
Basic EPS - Continuing Operations	-76.45	-93.47	-63.84	-33.67	-5.21
Basic Weighted Average Shares Outstanding	10.42M	10.39M	10.24M	10.29M	10.63M
Net EPS - Diluted	-76.45	-93.47	-63.84	-33.67	-5.21
Diluted EPS - Continuing Operations	-76.45	-93.47	-63.84	-33.67	-5.21
Diluted Weighted Average Shares Outstanding	10.42M	10.39M	10.24M	10.29M	10.63M
Normalized Basic EPS	-47.73	-58.3	-39.75	-18.56	-3.16
Normalized Diluted EPS	-47.73	-58.3	-39.75	-18.56	-3.16
American Depositary Receipts Ratio (ADR)	10	10	10	10	10
Supplemental Items
EBITDA	-752M	-860M	-538M	-271M	-33.22M
EBITA	-797M	-980M	-669M	-322M	-54.84M
EBIT	-797M	-980M	-669M	-322M	-54.84M
EBITDAR	-716M	-820M	-	-239M	-8.78M
Total Revenues (As Reported)	508M	563M	537M	516M	540M
Effective Tax Rate - (Ratio)	-0.11	-0.2	-0.37	-1.73	-2.89
Total Current Taxes	899K	1.98M	2.39M	5.88M	1.56M
Normalized Net Income	-497M	-606M	-407M	-191M	-33.62M
Supplemental Operating Expense Items
Selling and Marketing Expenses	303M	370M	248M	191M	165M
General and Administrative Expenses	462M	542M	438M	262M	126M
Research And Development Expense From Footnotes	368M	422M	347M	232M	166M
Net Rental Expense, Total	36.34M	39.71M	-	31.84M	24.44M
Imputed Operating Lease Interest Expense	6.69M	-	-	-	123K
Imputed Operating Lease Depreciation	29.65M	-	-	-	24.31M
Stock-Based Comp., COGS (Total)	1.5M	1.78M	2.31M	1.87M	1.19M
Stock-Based Comp., R&D Exp. (Total)	29.64M	52.87M	53.47M	30.68M	1.86M
Stock-Based Comp., S&M Exp. (Total)	9.61M	8.52M	9.66M	5.01M	2.76M
Stock-Based Comp., G&A Exp. (Total)	242M	264M	195M	118M	8.06M
Total Stock-Based Compensation	282M	327M	261M	156M	13.88M

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Assets
Cash And Equivalents	1.43B	905M	615M	520M	478M
Short Term Investments	65.63M	2.09M	13.4M	6.14M	2.4M
Total Cash And Short Term Investments	1.5B	908M	629M	526M	481M
Accounts Receivable, Total	135M	152M	150M	166M	182M
Other Receivables	111K	103K	1.18M	177K	70K
Notes Receivable	3.5M	-	-	-	-
Total Receivables	138M	152M	151M	166M	182M
Inventory	123M	130M	69.02M	62.62M	56.98M
Prepaid Expenses	-	-	-	-	-
Restricted Cash	7.8M	19.82M	120K	2.31M	2.7M
Other Current Assets, Total	54.79M	49.26M	35.67M	19.65M	16.14M
Total Current Assets	1.82B	1.26B	884M	777M	739M
Gross Property Plant And Equipment	567M	577M	548M	549M	532M
Accumulated Depreciation	-161M	-277M	-404M	-448M	-458M
Net Property Plant And Equipment	406M	300M	144M	100M	73.87M
Long-term Investments	910K	690K	337K	-	-
Other Intangibles, Total	5.15M	1.99M	964K	421K	284K
Loans Receivable Long-Term	-	5.1M	5.32M	-	-
Other Long-Term Assets, Total	45.14M	20.89M	5.09M	7.93M	7.63M
Total Assets	2.28B	1.59B	1.04B	885M	820M
Liabilities
Accounts Payable, Total	63.08M	50.95M	18.06M	33.75M	40.74M
Accrued Expenses, Total	107M	104M	65.37M	56.94M	51.99M
Short-term Borrowings	2.37M	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	200K
Current Portion of Leases	35M	37.24M	8.63M	24.57M	16.76M
Current Income Taxes Payable	7.69M	11.02M	20.62M	14.46M	16.38M
Unearned Revenue Current, Total	143M	148M	131M	118M	108M
Other Current Liabilities	14.14M	60.38M	20.14M	18.69M	13.08M
Total Current Liabilities	372M	411M	263M	266M	247M
Long-Term Debt	-	-	-	-	1.7M
Long-Term Leases	49.32M	13.55M	3.69M	27.75M	24.46M
Unearned Revenue Non Current	-	-	-	-	-
Other Non Current Liabilities	11.78M	4.12M	4.54M	10.42M	11.98M
Total Liabilities	433M	429M	272M	304M	285M
Preferred Stock Convertible	-	-	-	-	-
Preferred Stock - Others	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	137K	138K	137K	145K	141K
Additional Paid In Capital	4.28B	4.58B	4.85B	5B	5.01B
Retained Earnings	-2.23B	-3.2B	-3.85B	-4.2B	-4.26B
Treasury Stock	-	-58.92M	-65.9M	-63.26M	-57.19M
Comprehensive Income and Other	-207M	-166M	-162M	-158M	-162M
Total Common Equity	1.85B	1.16B	768M	581M	535M
Total Equity	1.85B	1.16B	768M	581M	535M
Total Liabilities And Equity	2.28B	1.59B	1.04B	885M	820M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	10.52M	10.27M	10.26M	10.77M	10.55M
ECS Total Common Shares Outstanding	10.51M	10.26M	10.24M	10.76M	10.52M
Book Value / Share	175.56	112.85	75.01	53.97	50.89
Tangible Book Value	1.84B	1.16B	767M	580M	535M
Tangible Book Value Per Share	175.07	112.66	74.92	53.93	50.86
Total Debt	86.68M	50.79M	12.32M	52.32M	43.12M
Net Debt	-1.41B	-857M	-616M	-474M	-438M
Debt Equivalent Oper. Leases	291M	318M	-	255M	195M
Equity Method Investments, Total	910K	690K	337K	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	81.03M	87.43M	42.7M	32.83M	28.44M
Inventories - Work In Process, Total	7.9M	7.59M	5.26M	15.48M	12.77M
Inventories - Finished Goods, Total	34.28M	35.31M	21.06M	14.32M	15.76M
Machinery, Total	298M	339M	348M	307M	301M
Full Time Employees	1.39K	1.14K	786	674	667
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	39.17M	42.91M	38.4M	45.87M	59.25M

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Net Income	-797M	-971M	-654M	-347M	-55.35M
Depreciation & Amortization - CF	44.6M	121M	131M	51.39M	21.62M
Depreciation & Amortization, Total	44.6M	121M	131M	51.39M	21.62M
Amortization of Deferred Charges, Total - (CF)	3.16M	3.35M	1.95M	813K	137K
(Gain) Loss From Sale Of Asset	178K	1.42M	1.01M	2.2M	-204K
(Gain) Loss on Sale of Investments - (CF)	-	-	-	247K	-
Asset Writedown & Restructuring Costs	-	-	-	35.13M	-
(Income) Loss On Equity Investments - (CF)	483K	294K	361K	93K	-
Stock-Based Compensation (CF)	282M	327M	261M	156M	13.88M
Provision and Write-off of Bad Debts	12.12M	24.92M	18.5M	10.54M	17.18M
Other Operating Activities, Total	38.23M	48.07M	36.07M	34.87M	33.68M
Change In Accounts Receivable	-49.77M	-42.16M	-16.4M	-26.8M	-33.23M
Change In Inventories	-67M	-21.65M	57.28M	2.51M	2.5M
Change In Accounts Payable	-5.1M	16.63M	-31.12M	18.89M	7.18M
Change in Unearned Revenues	68.21M	5.42M	-16.67M	-13.5M	-10.3M
Change in Other Net Operating Assets	-8.73M	30.6M	-45.24M	-17.63M	-25.53M
Cash from Operations	-478M	-457M	-256M	-92.26M	-28.44M
Capital Expenditure	-211M	-70.29M	-8.1M	-5.42M	-5.25M
Sale of Property, Plant, and Equipment	565K	2.41M	84K	1.56M	858K
Sale (Purchase) of Intangible assets	-2.53M	-185K	-1.28M	-558K	-
Investment in Marketable and Equity Securities, Total	295M	65.6M	-	-	-
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-5M	-	-	-
Cash from Investing	81.7M	-7.46M	-9.3M	-4.41M	-4.39M
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	2M
Total Debt Issued	-	-	-	-	2M
Short Term Debt Repaid, Total	-5M	-2.37M	-	-	-
Long-Term Debt Repaid, Total	-39.81M	-	-	-	-100K
Total Debt Repaid	-44.81M	-2.37M	-	-	-100K
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-4.27M	-71.83M	-6.98M	-72K	-
Issuance of Preferred Stock	-	-	-	-	-
Repurchase of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-3.82M	-12.04M	-41.86M	-	-
Cash from Financing	-52.9M	-86.24M	-48.83M	-72K	1.9M
Foreign Exchange Rate Adjustments	-37.01M	36.67M	3.86M	3.69M	-10.14M
Net Change in Cash	-486M	-514M	-310M	-93.05M	-41.07M
Supplemental Items
Cash Interest Paid	1.52M	877K	-	-	30K
Cash Income Tax Paid (Refund)	1.1M	98K	-	-	-
Levered Free Cash Flow	-305M	-220M	-57.45M	-7.71M	-22.79M
Unlevered Free Cash Flow	-304M	-220M	-57.45M	-7.71M	-22.77M
Change In Net Working Capital	-77.12M	-12.18M	23.86M	8.04M	18.88M
Net Debt Issued / Repaid	-44.81M	-2.37M	-	-	1.9M

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Profitability
Return on Assets	-20.16	-31.7	-31.84	-20.93	-4.02
Return on Total Capital	-22.64	-39.01	-42.05	-28.51	-5.66
Return On Equity %	-37.35	-64.67	-67.85	-51.38	-9.92
Return on Common Equity	-37.35	-64.67	-67.85	-51.38	-9.92
Margin Analysis
Gross Profit Margin %	71.7	67.47	67.59	70.26	74.67
SG&A Margin	156.7	167.17	127.56	87.73	53.98
EBITDA Margin %	-148.16	-152.63	-100.08	-52.55	-6.16
EBITA Margin %	-156.94	-174.07	-124.54	-62.51	-10.16
EBIT Margin %	-156.94	-174.07	-124.54	-62.51	-10.16
Income From Continuing Operations Margin %	-156.87	-172.44	-121.63	-67.2	-10.26
Net Income Margin %	-156.87	-172.44	-121.63	-67.2	-10.26
Net Avail. For Common Margin %	-156.87	-172.44	-121.63	-67.2	-10.26
Normalized Net Income Margin	-97.93	-107.55	-75.74	-37.03	-6.23
Levered Free Cash Flow Margin	-60.11	-39.09	-10.69	-1.49	-4.22
Unlevered Free Cash Flow Margin	-59.92	-39.09	-10.69	-1.49	-4.22
Asset Turnover
Asset Turnover	0.21	0.29	0.41	0.54	0.63
Fixed Assets Turnover	1.96	1.59	2.42	4.22	6.19
Receivables Turnover (Average Receivables)	4.14	3.93	3.57	3.27	3.1
Inventory Turnover (Average Inventory)	1.5	1.45	1.75	2.33	2.29
Short Term Liquidity
Current Ratio	4.89	3.06	3.36	2.92	2.99
Quick Ratio	4.38	2.57	2.96	2.6	2.68
Operating Cash Flow to Current Liabilities	-1.28	-1.11	-0.97	-0.35	-0.12
Days Sales Outstanding (Average Receivables)	88.16	92.77	102.32	111.92	117.63
Days Outstanding Inventory (Average Inventory)	242.84	252.56	208.83	157.02	159.72
Average Days Payable Outstanding	90.43	109.35	111.54	64.48	103.77
Cash Conversion Cycle (Average Days)	240.57	235.98	199.61	204.46	173.58
Long Term Solvency
Total Debt/Equity	4.7	4.38	1.6	9.01	8.06
Total Debt / Total Capital	4.49	4.2	1.58	8.26	7.46
LT Debt/Equity	2.67	1.17	0.48	4.78	4.89
Long-Term Debt / Total Capital	2.55	1.12	0.47	4.38	4.52
Total Liabilities / Total Assets	19.02	27.03	26.11	34.39	34.75
EBIT / Interest Expense	-518.92	-	-	-	-1.83K
EBITDA / Interest Expense	-466.23	-	-	-	-292.8
(EBITDA - Capex) / Interest Expense	-603.54	-	-	-	-467.77
Total Debt / EBITDA	-0.12	-0.06	-0.02	-0.22	-4.91
Net Debt / EBITDA	1.97	1.04	1.24	1.98	49.83
Total Debt / (EBITDA - Capex)	-0.09	-0.06	-0.02	-0.21	-3.07
Net Debt / (EBITDA - Capex)	1.52	0.96	1.22	1.94	31.19
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	18.13	10.9	-4.58	-4.02	4.6
Gross Profit, 1 Yr. Growth %	16	4.36	-4.42	-0.23	11.18
EBITDA, 1 Yr. Growth %	98.04	14.25	-37.43	-49.61	-87.74
EBITA, 1 Yr. Growth %	93.27	23	-31.73	-51.83	-82.99
EBIT, 1 Yr. Growth %	93.27	23	-31.73	-51.83	-82.99
Earnings From Cont. Operations, 1 Yr. Growth %	95.64	21.91	-32.7	-46.97	-84.03
Net Income, 1 Yr. Growth %	95.64	21.91	-32.7	-46.97	-84.03
Normalized Net Income, 1 Yr. Growth %	95.41	21.8	-32.8	-53.08	-82.4
Diluted EPS Before Extra, 1 Yr. Growth %	11.19	22.26	-31.7	-47.25	-84.54
Accounts Receivable, 1 Yr. Growth %	21.52	12.72	-1.39	10.87	9.67
Inventory, 1 Yr. Growth %	81.14	5.77	-47.04	-9.27	-9.02
Net Property, Plant and Equip., 1 Yr. Growth %	264.59	-26.18	-51.94	-30.41	-26.38
Total Assets, 1 Yr. Growth %	-14.44	-30.33	-34.49	-14.87	-7.33
Tangible Book Value, 1 Yr. Growth %	-23.88	-37.16	-33.63	-24.37	-7.83
Common Equity, 1 Yr. Growth %	-23.78	-37.23	-33.66	-24.41	-7.84
Cash From Operations, 1 Yr. Growth %	549.8	-4.41	-44.01	-63.93	-69.17
Capital Expenditures, 1 Yr. Growth %	179.09	-66.67	-88.47	-33.13	-3.14
Levered Free Cash Flow, 1 Yr. Growth %	1.31K	-27.87	-73.9	-86.58	195.51
Unlevered Free Cash Flow, 1 Yr. Growth %	1.33K	-27.65	-73.9	-86.58	195.27
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	15.35	14.46	2.87	-4.3	0.2
Gross Profit, 2 Yr. CAGR %	15.42	10.03	-0.13	-2.35	5.32
EBITDA, 2 Yr. CAGR %	133.28	50.42	-15.45	-43.85	-75.15
EBITA, 2 Yr. CAGR %	117.11	54.18	-8.36	-42.65	-71.37
EBIT, 2 Yr. CAGR %	117.11	54.18	-8.36	-42.65	-71.37
Earnings From Cont. Operations, 2 Yr. CAGR %	117.02	54.43	-9.42	-40.26	-70.9
Net Income, 2 Yr. CAGR %	117.02	54.43	-9.42	-40.26	-70.9
Normalized Net Income, 2 Yr. CAGR %	116.9	54.27	-9.53	-43.85	-71.26
Diluted EPS Before Extra, 2 Yr. CAGR %	-26.7	16.59	-8.62	-39.98	-71.44
Accounts Receivable, 2 Yr. CAGR %	22.47	17.04	5.43	4.56	10.27
Inventory, 2 Yr. CAGR %	45.6	38.42	-25.15	-30.68	-9.14
Net Property, Plant and Equip., 2 Yr. CAGR %	113.32	64.05	-40.44	-42.17	-28.42
Total Assets, 2 Yr. CAGR %	63.96	-22.79	-32.44	-25.32	-11.18
Tangible Book Value, 2 Yr. CAGR %	43.64	-30.84	-35.42	-29.15	-16.51
Common Equity, 2 Yr. CAGR %	43.87	-30.83	-35.47	-29.19	-16.54
Cash From Operations, 2 Yr. CAGR %	44.76	149.23	-26.84	-55.06	-66.65
Capital Expenditures, 2 Yr. CAGR %	115.7	-3.56	-80.4	-72.23	-19.52
Levered Free Cash Flow, 2 Yr. CAGR %	15.77	219.04	-56.62	-81.29	-37.02
Unlevered Free Cash Flow, 2 Yr. CAGR %	17.04	222.16	-56.55	-81.29	-37.05
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	34.47	13.85	7.73	0.52	-1.42
Gross Profit, 3 Yr. CAGR %	39.18	11.61	4.98	-0.16	1.97
EBITDA, 3 Yr. CAGR %	76.48	83.88	12.28	-28.85	-66.19
EBITA, 3 Yr. CAGR %	70.29	79.65	17.52	-26.04	-61.75
EBIT, 3 Yr. CAGR %	70.29	79.65	17.52	-26.04	-61.75
Earnings From Cont. Operations, 3 Yr. CAGR %	64.96	79.07	17.09	-24.23	-61.52
Net Income, 3 Yr. CAGR %	64.96	79.07	17.09	-24.23	-61.52
Normalized Net Income, 3 Yr. CAGR %	64.89	78.94	16.94	-27.31	-61.86
Diluted EPS Before Extra, 3 Yr. CAGR %	-9.7	-13.07	-2.44	-23.91	-61.81
Accounts Receivable, 3 Yr. CAGR %	55.9	19.13	10.54	7.21	6.24
Inventory, 3 Yr. CAGR %	35.93	30.89	0.49	-20.19	-24.1
Net Property, Plant and Equip., 3 Yr. CAGR %	80.1	49.77	8.96	-37.27	-37.32
Total Assets, 3 Yr. CAGR %	82.86	23.27	-26.91	-27.03	-19.75
Tangible Book Value, 3 Yr. CAGR %	44.97	9.04	-31.78	-31.93	-22.66
Common Equity, 3 Yr. CAGR %	45.15	9.12	-31.79	-31.98	-22.69
Cash From Operations, 3 Yr. CAGR %	47.55	26.06	51.51	-42.2	-60.36
Capital Expenditures, 3 Yr. CAGR %	104.76	15.74	-52.49	-70.49	-57.89
Levered Free Cash Flow, 3 Yr. CAGR %	39.58	-1.12	38.49	-70.66	-53.05
Unlevered Free Cash Flow, 3 Yr. CAGR %	44.41	-0.3	39.39	-70.63	-53.06
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	38.34	20.81	6.21	4.65
Gross Profit, 5 Yr. CAGR %	-	39.59	21.88	5.8	5.12
EBITDA, 5 Yr. CAGR %	-	53.82	31.48	14.41	-38.58
EBITA, 5 Yr. CAGR %	-	51.99	32.91	13.78	-33.2
EBIT, 5 Yr. CAGR %	-	51.99	32.91	13.78	-33.2
Earnings From Cont. Operations, 5 Yr. CAGR %	-	49.22	29.79	15.43	-32.91
Net Income, 5 Yr. CAGR %	-	49.22	29.79	15.43	-32.91
Normalized Net Income, 5 Yr. CAGR %	-	49.16	29.69	12.56	-33.29
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-1.74	-9.27	-25.04	-40.32
Accounts Receivable, 5 Yr. CAGR %	-	29.76	33.32	13.07	10.43
Inventory, 5 Yr. CAGR %	-	50.63	7.07	1.51	-3.48
Net Property, Plant and Equip., 5 Yr. CAGR %	-	37.66	15.69	2.36	-7.9
Total Assets, 5 Yr. CAGR %	-	31.72	22.78	0.88	-20.98
Tangible Book Value, 5 Yr. CAGR %	-	25.42	4.91	-8.23	-26.04
Common Equity, 5 Yr. CAGR %	-	25.49	4.95	-8.21	-26.05
Cash From Operations, 5 Yr. CAGR %	-	27.86	11.45	-16.55	-17.3
Capital Expenditures, 5 Yr. CAGR %	-	25.65	-19.89	-34.61	-41.34
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-12.54	-49.19	1.05
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-10.68	-48.94	1.42